{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T23:33:15Z","timestamp":1793143995157,"version":"4.5.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"15","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ejcancer.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.ejca.2014.07.014","type":"journal-article","created":{"date-parts":[[2014,8,7]],"date-time":"2014-08-07T14:00:32Z","timestamp":1407420032000},"page":"2602-2610","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":147,"title":["L1 cell adhesion molecule is a strong predictor for distant recurrence and overall survival in early stage endometrial cancer: Pooled PORTEC trial results"],"prefix":"10.1016","volume":"50","author":[{"given":"T.","family":"Bosse","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.A.","family":"Nout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Stelloo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Dreef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.W.","family":"Nijman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.M.","family":"J\u00fcrgenliemk-Schulz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.J.","family":"Jobsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.L.","family":"Creutzberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.T.H.B.M.","family":"Smit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.ejca.2014.07.014_b0005","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.1016\/S0020-7292(06)60031-3","article-title":"Carcinoma of the corpus uteri. FIGO 26th annual report on the results of treatment in gynecological cancer","volume":"95","author":"Creasman","year":"2006","journal-title":"Int J Gynaecol Obstet"},{"issue":"21","key":"10.1016\/j.ejca.2014.07.014_b0010","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1093\/jnci\/djs374","article-title":"Adjuvant radiotherapy for stage I endometrial cancer: an updated Cochrane systematic review and meta-analysis","volume":"104","author":"Kong","year":"2012","journal-title":"J Natl Cancer Inst"},{"issue":"15","key":"10.1016\/j.ejca.2014.07.014_b0015","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1093\/jnci\/djt144","article-title":"L1CAM in early-stage type I endometrial cancer: results of a large multicenter evaluation","volume":"105","author":"Zeimet","year":"2013","journal-title":"J Natl Cancer Inst"},{"issue":"9387","key":"10.1016\/j.ejca.2014.07.014_b0020","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S0140-6736(03)14342-5","article-title":"L1 expression as a predictor of progression and survival in patients with uterine and ovarian carcinomas","volume":"362","author":"Fogel","year":"2003","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.ejca.2014.07.014_b0025","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/path.2673","article-title":"Up-regulation of L1CAM is linked to loss of hormone receptors and E-cadherin in aggressive subtypes of endometrial carcinomas","volume":"220","author":"Huszar","year":"2010","journal-title":"J Pathol"},{"issue":"2","key":"10.1016\/j.ejca.2014.07.014_b0030","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0304-3835(02)00513-X","article-title":"L1 adhesion molecule (CD 171) in development and progression of human malignant melanoma","volume":"189","author":"Fogel","year":"2003","journal-title":"Cancer Lett"},{"issue":"4","key":"10.1016\/j.ejca.2014.07.014_b0035","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1083\/jcb.200408051","article-title":"L1, a novel target of beta-catenin signaling, transforms cells and is expressed at the invasive front of colon cancers","volume":"168","author":"Gavert","year":"2005","journal-title":"J Cell Biol"},{"issue":"34","key":"10.1016\/j.ejca.2014.07.014_b0040","doi-asserted-by":"crossref","first-page":"4766","DOI":"10.1038\/onc.2010.230","article-title":"L1CAM-integrin interaction induces constitutive NF-kappaB activation in pancreatic adenocarcinoma cells by enhancing IL-1beta expression","volume":"29","author":"Kiefel","year":"2010","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.ejca.2014.07.014_b0045","first-page":"1109","article-title":"Expression and prognostic value of L1-CAM in breast cancer","volume":"22","author":"Schroder","year":"2009","journal-title":"Oncol Rep"},{"key":"10.1016\/j.ejca.2014.07.014_b0050","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/1476-4598-10-127","article-title":"L1CAM protein expression is associated with poor prognosis in non-small cell lung cancer","volume":"10","author":"Tischler","year":"2011","journal-title":"Mol Cancer"},{"issue":"4","key":"10.1016\/j.ejca.2014.07.014_b0055","doi-asserted-by":"crossref","first-page":"374","DOI":"10.4161\/cam.20832","article-title":"L1CAM: a major driver for tumor cell invasion and motility","volume":"6","author":"Kiefel","year":"2012","journal-title":"Cell Adh Migr"},{"issue":"28","key":"10.1016\/j.ejca.2014.07.014_b0060","doi-asserted-by":"crossref","first-page":"28880","DOI":"10.1074\/jbc.M404075200","article-title":"Extracellular signal-regulated kinase (ERK)-dependent gene expression contributes to L1 cell adhesion molecule-dependent motility and invasion","volume":"279","author":"Silletti","year":"2004","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.ejca.2014.07.014_b0065","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/ijc.21880","article-title":"The adhesion molecule L1 (CD171) promotes melanoma progression","volume":"119","author":"Meier","year":"2006","journal-title":"Int J Cancer"},{"issue":"7","key":"10.1016\/j.ejca.2014.07.014_b0070","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/jso.21880","article-title":"L1 cell adhesion molecule (L1CAM) expression at the cancer invasive front is a novel prognostic marker of pancreatic ductal adenocarcinoma","volume":"103","author":"Tsutsumi","year":"2011","journal-title":"J Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejca.2014.07.014_b0075","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1309\/AJCP63NRBNGCTXVF","article-title":"Expression of l1 cell adhesion molecule and morphologic features at the invasive front of colorectal cancer","volume":"136","author":"Kajiwara","year":"2011","journal-title":"Am J Clin Pathol"},{"issue":"1","key":"10.1016\/j.ejca.2014.07.014_b0080","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/1756-9966-32-66","article-title":"L1 and epithelial cell adhesion molecules associated with gastric cancer progression and prognosis in examination of specimens from 601 patients","volume":"32","author":"Wang","year":"2013","journal-title":"J Exp Clin Cancer Res"},{"issue":"10","key":"10.1016\/j.ejca.2014.07.014_b0085","first-page":"4033","article-title":"Expression of L1 cell adhesion molecule is a significant prognostic factor in pT3-stage gastric cancer","volume":"29","author":"Kodera","year":"2009","journal-title":"Anticancer Res"},{"issue":"3","key":"10.1016\/j.ejca.2014.07.014_b0090","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1158\/1078-0432.1190.11.3","article-title":"The L1 cell adhesion molecule is induced in renal cancer cells and correlates with metastasis in clear cell carcinomas","volume":"11","author":"Allory","year":"2005","journal-title":"Clin Cancer Res"},{"issue":"12","key":"10.1016\/j.ejca.2014.07.014_b0095","first-page":"4919","article-title":"L1-CAM as a target for treatment of cancer with monoclonal antibodies","volume":"29","author":"Weidle","year":"2009","journal-title":"Anticancer Res"},{"issue":"9213","key":"10.1016\/j.ejca.2014.07.014_b0100","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/S0140-6736(00)02139-5","article-title":"Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC study group. Post operative radiation therapy in endometrial carcinoma","volume":"355","author":"Creutzberg","year":"2000","journal-title":"Lancet"},{"issue":"13","key":"10.1016\/j.ejca.2014.07.014_b0105","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1200\/JCO.2010.32.4590","article-title":"Long-term outcome and quality of life of patients with endometrial carcinoma treated with or without pelvic radiotherapy in the post operative radiation therapy in endometrial carcinoma 1 (PORTEC-1) trial","volume":"29","author":"Nout","year":"2011","journal-title":"J Clin Oncol"},{"issue":"9717","key":"10.1016\/j.ejca.2014.07.014_b0110","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0140-6736(09)62163-2","article-title":"Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial","volume":"375","author":"Nout","year":"2010","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.ejca.2014.07.014_b0115","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1038\/modpathol.2013.96","article-title":"Loss of ARID1A expression and its relationship with PI3K\u2013Akt pathway alterations, TP53 and microsatellite instability in endometrial cancer","volume":"26","author":"Bosse","year":"2013","journal-title":"Mod Pathol"},{"issue":"2","key":"10.1016\/j.ejca.2014.07.014_b0120","doi-asserted-by":"crossref","first-page":"e180","DOI":"10.5301\/jbm.5000055","article-title":"A standardized staining protocol for L1CAM on formalin-fixed, paraffin-embedded tissues using automated platforms","volume":"29","author":"Fogel","year":"2014","journal-title":"Int J Biol Markers"},{"issue":"28","key":"10.1016\/j.ejca.2014.07.014_b0125","doi-asserted-by":"crossref","first-page":"3973","DOI":"10.1038\/sj.onc.1209423","article-title":"Acquired chemoresistance in pancreatic carcinoma cells: induced secretion of IL-1beta and NO lead to inactivation of caspases","volume":"25","author":"Muerkoster","year":"2006","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.ejca.2014.07.014_b0130","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1158\/0008-5472.CAN-09-3730","article-title":"Therapeutic antibodies to human L1CAM: functional characterization and application in a mouse model for ovarian carcinoma","volume":"70","author":"Wolterink","year":"2010","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.ejca.2014.07.014_b0135","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.canlet.2011.12.035","article-title":"Combined treatment of L1CAM antibodies and cytostatic drugs improve the therapeutic response of pancreatic and ovarian carcinoma","volume":"319","author":"Schafer","year":"2012","journal-title":"Cancer Lett"},{"issue":"2","key":"10.1016\/j.ejca.2014.07.014_b0140","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1158\/0008-5472.CAN-05-1818","article-title":"Efficient inhibition of intra-peritoneal tumor growth and dissemination of human ovarian carcinoma cells in nude mice by anti-L1-cell adhesion molecule monoclonal antibody treatment","volume":"66","author":"Arlt","year":"2006","journal-title":"Cancer Res"},{"issue":"2","key":"10.1016\/j.ejca.2014.07.014_b0145","doi-asserted-by":"crossref","first-page":"462","DOI":"10.18632\/oncotarget.1552","article-title":"Role of miR-34a as a suppressor of L1CAM in endometrial carcinoma","volume":"5","author":"Schirmer","year":"2014","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.ejca.2014.07.014_b0150","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/jcp.51.1.13","article-title":"Neural cell adhesion molecule L1 in gliomas: correlation with TGF-beta and p53","volume":"51","author":"Tsuzuki","year":"1998","journal-title":"J Clin Pathol"},{"issue":"10","key":"10.1016\/j.ejca.2014.07.014_b0155","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s12094-012-0866-3","article-title":"The EMT signaling pathways in endometrial carcinoma","volume":"14","author":"Colas","year":"2012","journal-title":"Clin Transl Oncol"},{"issue":"11","key":"10.1016\/j.ejca.2014.07.014_b0160","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1517\/14712598.8.11.1749","article-title":"L1-CAM in cancerous tissues","volume":"8","author":"Gavert","year":"2008","journal-title":"Expert Opin Biol Ther"},{"issue":"16","key":"10.1016\/j.ejca.2014.07.014_b0165","doi-asserted-by":"crossref","first-page":"7703","DOI":"10.1158\/0008-5472.CAN-07-0991","article-title":"Expression of L1-CAM and ADAM10 in human colon cancer cells induces metastasis","volume":"67","author":"Gavert","year":"2007","journal-title":"Cancer Res"},{"issue":"10","key":"10.1016\/j.ejca.2014.07.014_b0170","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1093\/carcin\/bgs220","article-title":"EMT-associated up-regulation of L1CAM provides insights into L1CAM-mediated integrin signalling and NF-kappaB activation","volume":"33","author":"Kiefel","year":"2012","journal-title":"Carcinogenesis"},{"issue":"1","key":"10.1016\/j.ejca.2014.07.014_b0175","first-page":"257","article-title":"Binding of the transcription factor Slug to the L1CAM promoter is essential for transforming growth factor-beta1 (TGF-beta)-induced L1CAM expression in human pancreatic ductal adenocarcinoma cells","volume":"38","author":"Geismann","year":"2011","journal-title":"Int J Oncol"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804914008144?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804914008144?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,15]],"date-time":"2023-07-15T19:52:20Z","timestamp":1689450740000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804914008144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":35,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S0959804914008144"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2014.07.014","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"L1 cell adhesion molecule is a strong predictor for distant recurrence and overall survival in early stage endometrial cancer: Pooled PORTEC trial results","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2014.07.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}